Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment



Rating:

Share or cite this content

Citations should be made in the following way:
M. OLIVEIRA (São Carlos, Brazil), G. Back (São Carlos, Brazil), C. Goulart (São Carlos, Brazil), B. Domingos (São Carlos, Brazil), R. Arena (Chicago, United States of America), A. Borghi-Silva (São Carlos, Brazil). Do hospitalized COVID-19 patients have endothelial vascular dysfunction? A cohort study. 2659

Member's Comments

No comment yet.

Related content which might interest you: Systemic endothelial dysfunction in COPD patients – study on 60 cases Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004 Evaluation of endothelial dysfunction at the patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004 1 year evolution of COPD patients systemic endothelial dysfunction Source: Eur Respir J 2005; 26: Suppl. 49, 718s Year: 2005 Pulmonary vascular disease (PVD) in patients with Sjögren syndrome - a prospective cross-sectional study Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019 Determinants of endothelial function in patients with COPD Source: Eur Respir J 2013; 42: 1194-1204 Year: 2013 Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial Source: Eur Respir J, 50 (4) 1701183; 10.1183/13993003.01183-2017 Year: 2017 Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Hypoxaemia and endothelial dysfunctional in patients with COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 New markers of endothelial dysfunction in patients with COPD Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Correction of endothelial dysfunction in patients with COPD, IPF Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 New markers of endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 143s Year: 2007 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy. Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Correction of endothelial dysfunction in patients with pulmonary diseases Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 How do patients with vascular rings/slings die? Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease Year: 2008 The role of smoking in development of endothelial dysfunction in patients with COPD in combination with AH Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 Do COPD patients have a pulmonary vascular phenotype? Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019 Vascular dysfunction and systemic inflammation in patients with COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011 Respiratory function in chronic stroke patients: an observational study. Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions Year: 2021 Prevalence of pulmonary embolism in patients with isolated syncope in the emergency department: the PEEPS multicenter prospective cohort study. Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019